跳至主要内容
临床试验/NCT03235765
NCT03235765Unknown不适用

Clinical Validity of Oncogenic Driver Genes Detected From Circulating Tumor DNA in Blood of Lung Cancer Patients

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年3月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Concordance rate

研究概览

简要总结

Molecular profiling of lung cancers using circulating tumor DNA (ctDNA) in the blood of patients is rapidly becoming established as a useful source of information to aid clinical decision-making. This study is aimed to to compare concordance rate between tissue based cancer panel analysis and blood based cancer panel analysis in lung cancer patients (both by NGS technique).

详细描述

This study is comprised of two cohorts as below:

Cohort A: inoperable, untreated, non-small cell lung cancer patients

Cohort B: non-small cell lung cancer patients who are in the treatment with targeted agents including immune checkpoint inhibitors

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of informed consent prior to any study specific procedures, sampling, and analyses
  • Pathologically confirmed non-small cell lung cancer
  • Male or female, aged at least 20 years
  • Matches one of two criteria :
  • Cohort A: Patients who are diagnosed with metastatic/recurrent non-small cell lung cancer and planned to receive first line chemotherapy
  • Cohort B: Patients with recurrent/metastatic non-small cell lung cancer who have been receiving molecular targeted therapy, including immune checkpoint inhibitor, and have tumor shrinkage with the agent.

排除标准

  • Any concurrent and/or other active malignancy that has required treatment within 3 years
  • Patients with mixed small cell histology
  • Life expectancy less than 3 months
  • Insufficient tissue for NGS test

结局指标

主要结局

Concordance rate

时间窗: an average of one year

Concordance rate of genomic change between tumor tissue (FFPE) and ctDNA

次要结局

  • Frequency of actionable genomic change(an average of one year)
  • Overall survival by treatment(an average of one year)
  • Overall survival(an average of one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jong-Seok Lee

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验